Stakeholders from Across the State Attended the OneFlorida Cancer Control Alliance’s First Annual Stakeholder Meeting
On January 26, the OneFlorida Cancer Control Alliance held its first Annual Stakeholder Meeting at the Lake Nona UF Research and Academic Center in Orlando. The goal of the meeting was to bring together all the OneFlorida Cancer Control Alliance stakeholders to engage in strategic planning for 2015.
The OneFlorida Cancer Control Alliance (OneFlorida CCA) is a research alliance formed by the OneFlorida Clinical Research Consortium to strengthen statewide infrastructure and reduce health disparities in cardiovascular disease and cancer related to tobacco use. The OneFlorida CCA partners include:
- UF Health and the UF Health Cancer Center
- UF Health Cancer Center at Orlando Health
- University of Miami Health System and Sylvester Comprehensive Cancer Center
- Bond Community Health Center, Inc.
- Edward Waters College
- Florida A&M University
- Florida State University and Their Practice Partners
- Health Choice Network of Florida
- Tallahassee Memorial Regional Cancer Center
- Florida Department of Health
- Florida Health Equity Research Institute
The event started out with a working lunch, followed by an introduction by David Nelson, M.D., director of the Clinical and Translational Science Institute at the University of Florida, and an overview of the OneFlorida CCA goals by Betsy Shenkman, Ph.D., chair of the Department of Health Outcomes & Policy at the University of Florida. This led into a discussion session where various key features of the OneFlorida CCA were presented to the stakeholders, giving them a chance to see what is currently being produced for the OneFlorida CCA as well as an opportunity to provide their input. Highlights of the event included uniting key partners through a shared research infrastructure, a focus on improving health care quality through well-designed multisite studies and the future use of the OneFlorida Clinical Research Consortium as a means of mentoring new researchers in the field of implementation science.
“Ultimately, our goal is to work together to improve health, health care and health policy for all Floridians,” said Shenkman, who is the principal investigator for the $1.6 million James and Esther King Biomedical Research Program grant that is funding the alliance. “The annual stakeholder meeting proved to be an important venue for the open exchange of ideas. We appreciated the roles our varied stakeholders have played in making this alliance possible, and we look forward to our continued collaboration in the OneFlorida Cancer Control Alliance and other OneFlorida initiatives.”
To view the minutes from the event, please click here.